-
New Triple Combination Therapy Available in U.S. for Cystic Fibrosis Treatment
Trikafta targets most common mutation The U.S. Food and Drug Administration recently approved Trikafta, the first triple combination…
Trikafta targets most common mutation The U.S. Food and Drug Administration recently approved Trikafta, the first triple combination…